3649 results for «635»

Filter By

3649 results

TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAV in TAV for an 8-year

TAVI in bicuspid aortic valve disease - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France

TAVI in bicuspid aortic

GulfPCR-GIM 2019 Opening Ceremony

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover the slides presented during GulfPCR-GIM 2019 Opening Ceremony, the leading-edge interventional course in the Middle East, and learn more about the course directors, the programme committee members, the sessions and the live centers.

GulfPCR-GIM 2019 Opening Ceremony

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial

29 Mar 2025

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

Author

Aaysha Cader
Ali Nazmi Calik

Author

Ali Nazmi Calik
Routine cerebral embolic protection in TAVI: the British Heart Foundation (BHF) PROTECT-TAVI trial

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial

04 Nov 2021

Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....

Nicola Ryan

Author

Nicola Ryan
FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI

29 Jan 2026

Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.

This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...

Akiko Masumoto

Author

Akiko Masumoto

Author

Chiara De Biase
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI
Didn’t find what you were looking for?